Pfizer Must Face Trimmed Robitussin Labeling Suit
By Hannah Albarazi · November 16, 2021, 6:14 PM EST
Pharmaceutical giant Pfizer won the partial dismissal of a proposed class action in New York federal court Monday accusing it of misleading consumers with its "Maximum Strength" labeling of Robitussin cough...
To view the full article, register now.